- Home
- CGBD vs CERT Comparison
CGBD vs CERT Comparison
Compare CGBD & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGBD | CERT |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | 2500 | N/A |
| Industry | Finance: Consumer Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 826.2M | 860.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CGBD | CERT |
|---|---|---|
| Price | $10.96 | $4.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $12.92 | $11.67 |
| AVG Volume (30 Days) | 598.3K | ★ 3.0M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | ★ 14.42% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $3.74 | $4.18 |
| Revenue Next Year | $1.80 | $5.39 |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $10.64 | $4.45 |
| 52 Week High | $14.32 | $13.88 |
Technical Indicators
Market Signals| Indicator | CGBD | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 29.39 |
| Support Level | $10.68 | N/A |
| Resistance Level | $12.17 | $6.47 |
| Average True Range (ATR) | 0.29 | 0.31 |
| MACD | -0.10 | -0.14 |
| Stochastic Oscillator | 11.05 | 11.22 |
Price Performance
Historical ComparisonAbout CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.